Defibrillator News and Research

Latest Defibrillator News and Research

Rescu receives $50,000 grant to teach 22 minute CPR course to high school students

Researchers led by St. Michael's Hospital will be teaching a quick, inexpensive method of cardio-pulmonary resuscitation to some Toronto-area high school students this fall.

4 Nov 2010

Defibtech named one of Connecticut’s 40 fastest growing technology companies

Defibtech, LLC, a leading innovator in the Automated External Defibrillator (AED) market, has been named as a 2010 Marcum Tech Top 40 winner, a celebration of the 40 fastest growing companies in Connecticut, and was honored on October 28, 2010 at the Tech Top 40 awards program at the Oakdale Theater in Wallingford, Conn. This is the fourth year that Defibtech has been named as one of the fastest growing technology companies in Connecticut. Selection was based on the percentage revenue growth during the four year period from 2006-2009.

2 Nov 2010

Spectranetics 2010 third quarter revenue increases 3% to $29.6 million

Spectranetics Corporation today reported financial results for the three and nine months ended September 30, 2010.

27 Oct 2010

Genetic code of sudden death cardiac killer cracked

Researchers in Newfoundland have cracked the genetic code of a sudden death cardiac killer.

26 Oct 2010

Stereotaxis launches Odyssey Interventional Network portal for global cardiovascular community

Stereotaxis, Inc. announced today that it launched the Odyssey Interventional Network, a training and educational video sharing web portal for the global cardiovascular community. The portal will showcase innovative electrophysiology (EP) and interventional cardiology (IC) procedures from leading centers around the world.

21 Oct 2010

CIED implantation with AIGISRx Antibacterial Envelope reduces overall infection rate

Patients undergoing CIED (Cardiac Implantable Electronic Device) implantation with TYRX, Inc.'s FDA-cleared AIGISRx Antibacterial Envelope enjoyed a 99.5% rate of successful implantation with an overall infection rate of 0.48% in the first 1.9 months following the procedure, as reported in newly published results of TYRX's COMMAND Clinical Study.

20 Oct 2010

New emergency care guidelines simplify CPR

New emergency care guidelines simplify performing cardiopulmonary resuscitation (CPR) and highlight the need for high quality CPR by addressing some of the barriers to performing CPR. The Heart and Stroke Foundation of Canada, co-author of the 2010 Guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC), released the guidelines today.

18 Oct 2010

Hands only CPR effective: New guidelines

According to latest changes made to CPR guidelines rescuers need to start with hard, fast chest presses before giving mouth-to-mouth. The change is termed as “the simplest step first” for traditional CPR, said Dr Michael Sayre, an emergency doctor at Ohio State University Medical Centre and co-author of the guidelines issued by the American Heart Association.

17 Oct 2010

Chest compression-only method of CPR better than standard CPR

Heart attack patients whose hearts have stopped beating and who receive cardiopulmonary resuscitation (CPR) from bystanders fare better if their resuscitators skip the rescue breaths and do only chest compression, according to a study led by researchers at Washington University School of Medicine in St. Louis.

15 Oct 2010

BIOTRONIK announces European release of TI Trend Chart

BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.

15 Oct 2010

Sudden cardiac arrest survivors to gather at SCAA Annual Meeting

A nationwide gathering of sudden cardiac arrest (SCA) survivors, emergency responders and civilian rescuers will mark SCA Awareness Month with a Survivors & Heroes Celebration on Friday, October 8 at 6:00 p.m. at the Marriott City Center in Pittsburgh, Pennsylvania.

7 Oct 2010

BIOTRONIK's EchoCRT clinical trial design published in European Heart Journal

BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and sponsor of clinical research to advance patient care and evidence-based medicine, announced the publication in the September 23, 2010 issue of the European Heart Journal of a peer-reviewed article that describes the rationale for the echocardiographic methods and dyssynchrony cutoff values selected for the EchoCRT study.

6 Oct 2010

Defibtech extends availability of Lifeline View Automatic External Defibrillator into Europe

Defibtech, LLC, a leading innovator in the Automated External Defibrillator (AED) market, today announced its first international shipment of the Lifeline View™ Automatic External Defibrillator to Medizon, one of Defibtech's largest international distributors and the exclusive distributor for the Netherlands. This shipment of the Lifeline View AED adds to the more than 100,000 Defibtech AEDs shipped worldwide.

30 Sep 2010

ACT updates myoblast program for heart failure treatment

Advanced Cell Technology, a leader in the field of regenerative medicine, provided an update today on the status of its myoblast program. The program has successfully and safely completed Phase I human clinical trials in more than forty patients in over four independent studies.

30 Sep 2010

Cardiac Science launches MTWA module with Quinton Q-Stress systems

Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, today announced the launch of a Microvolt T-Wave Alternans (MTWA) module that integrates with its industry leading Quinton Q-Stress cardiac stress systems.

21 Sep 2010

NQF endorses 8 outcome measures for pulmonary, cardiovascular conditions and care provided in ICU

To improve healthcare quality and give patients and providers more information about the results of care, the National Quality Forum (NQF) has endorsed eight outcome measures for pulmonary and cardiovascular conditions and care provided in the intensive care unit (ICU). This is the first in a set of patient outcome measures NQF is reviewing.

20 Sep 2010

FDA approves expanded indication for Boston Scientific's CRT-Ds

Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The exclusive expanded indication is effective immediately and makes Boston Scientific CRT-Ds the only devices approved by the FDA for patients in all New York Heart Association (NYHA) classes of heart failure.

17 Sep 2010

FDA approves CRT-D device to treat heart failure patients

The U.S. Food and Drug Administration today approved a new indication for three cardiac resynchronization therapy defibrillators (CRT-D) used to treat certain heart failure patients.

17 Sep 2010

Recommendations for developing novel therapies for hypertrophic cardiomyopathy

16 Sep 2010

Researchers recommend mechanism to identify hypertrophic cardiomyopathy

An abrupt, fatal heart attack in a young athlete on the playing field is a tragedy destined to repeat itself over and over until more is understood about hypertrophic cardiomyopathy (HCM), a genetic disorder that is the most common cause of sudden death in young people but which affects people of all ages. So says a task force of cardiologists and cardiac biologists, headed by Thomas L. Force, M.D., James C. Wilson Professor of Medicine at Thomas Jefferson University, in the September 14th online edition of the journal Circulation.

15 Sep 2010